News
12h
Pharmaceutical Technology on MSNJ&J’s Tremfya gains EC marketing authorisation for ulcerative colitisThe European Commission (EC) has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya (guselkumab) to treat ...
This segment is sponsored by RGC Glass. The Crohn’s & Colitis Foundation is a non-profit, volunteer-driven organization ...
2d
RSVP Live on MSNArmagh's Niall Grimley found colitis diagnosis hard: 'It took me years to accept the disease'Gogglebox Ireland star Sarah Reilly, from Dundalk, Co. Louth, was diagnosed with Crohn’s disease in 2017 and she opened up ...
According to the Crohn’s and Colitis Foundation, nearly 1 in every 100 Americans are diagnosed with inflammatory bowel ...
J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current ...
Biosimilars are proving to be a game-changing solution in the fight against inflammatory bowel disease (IBD), offering a cost ...
Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...
Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer ...
Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...
The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...
For anyone with ulcerative colitis (UC), remission is a beautiful ... One mistake many of us make, however, is to deviate from our treatment plan when we’re enjoying a remission period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results